<DOC>
	<DOCNO>NCT01029379</DOCNO>
	<brief_summary>Propofol , ( 2,6-diisopropylphenol ) short-acting anesthetic drug use induction maintenance anesthesia . The aim study evaluate plasma concentration propofol relation depth anesthesia , measure continuous EEG correlate plasma concentration genetic analysis liver enzymes responsible drug elimination . Our hypothesis individual requirement Propofol plasma concentration depend genetic difference drug elimination . 200 patient , ASA classification 1 , plan elective surgery duration least 30 minute include study .</brief_summary>
	<brief_title>Pharmacogenetics Propofol Depth Anesthesia</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<criteria>Healthy caucasian patent , ( ASAclassification 1 ) plan elective surgery , body mass index 2030 , free analgetic drug &gt; 12 hour prior anesthesia Pregnancy , Smoking , allergy propofol peanut , alcohol abuse , noncaucasian</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>propofol</keyword>
	<keyword>depth anesthesia</keyword>
	<keyword>pharmacogenetics</keyword>
	<keyword>Depth anesthesia correlation plasma concentration propofol</keyword>
</DOC>